43 related articles for article (PubMed ID: 26956920)
21. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T
AAPS PharmSciTech; 2013 Mar; 14(1):133-40. PubMed ID: 23242556
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam.
Duangjit S; Obata Y; Sano H; Onuki Y; Opanasopit P; Ngawhirunpat T; Miyoshi T; Kato S; Takayama K
Biol Pharm Bull; 2014; 37(2):239-47. PubMed ID: 24225259
[TBL] [Abstract][Full Text] [Related]
23. Topical delivery of drugs for the effective treatment of fungal infections of skin.
Akhtar N; Verma A; Pathak K
Curr Pharm Des; 2015; 21(20):2892-913. PubMed ID: 25925110
[TBL] [Abstract][Full Text] [Related]
24. Low-dose meloxicam (Vivlodex) for osteoarthritis pain.
Med Lett Drugs Ther; 2016 Mar; 58(1490):35-6. PubMed ID: 26963155
[No Abstract] [Full Text] [Related]
25. Topical and cutaneous delivery using nanosystems.
Roberts MS; Mohammed Y; Pastore MN; Namjoshi S; Yousef S; Alinaghi A; Haridass IN; Abd E; Leite-Silva VR; Benson H; Grice JE
J Control Release; 2017 Feb; 247():86-105. PubMed ID: 28024914
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous delivery of natural antioxidants: the enhancement approaches.
Aljuffali IA; Hsu CY; Lin YK; Fang JY
Curr Pharm Des; 2015; 21(20):2745-57. PubMed ID: 25925121
[TBL] [Abstract][Full Text] [Related]
27. [Meloxicam: intramuscular administration in rheumatology].
Tsvetkova ES
Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
[No Abstract] [Full Text] [Related]
28. Novel penetration enhancers for skin applications: a review.
Parhi R; Suresh P; Mondal S; Kumar PM
Curr Drug Deliv; 2012 Mar; 9(2):219-30. PubMed ID: 22023208
[TBL] [Abstract][Full Text] [Related]
29. Microemulsions as transdermal drug delivery systems for nonsteroidal anti-inflammatory drugs (NSAIDs): a literature review.
Benbow T; Campbell J
Drug Dev Ind Pharm; 2019 Dec; 45(12):1849-1855. PubMed ID: 31617433
[TBL] [Abstract][Full Text] [Related]
30. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
Al-Lawati H; Binkhathlan Z; Lavasanifar A
Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
[TBL] [Abstract][Full Text] [Related]
31. Passive delivery of protein drugs through transdermal route.
Chaulagain B; Jain A; Tiwari A; Verma A; Jain SK
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):472-487. PubMed ID: 29378433
[TBL] [Abstract][Full Text] [Related]
32. Nanocarrier Based Topical Drug Delivery- A Promising Strategy for Treatment of Skin Cancer.
Jain R; Sarode I; Singhvi G; Dubey SK
Curr Pharm Des; 2020; 26(36):4615-4623. PubMed ID: 32851954
[TBL] [Abstract][Full Text] [Related]
33. Occlusion vs. skin barrier function.
Zhai H; Maibach HI
Skin Res Technol; 2002 Feb; 8(1):1-6. PubMed ID: 12005114
[TBL] [Abstract][Full Text] [Related]
34. Formulation approaches for improved retinoids delivery in the treatment of several pathologies.
Gonçalves A; Estevinho BN; Rocha F
Eur J Pharm Biopharm; 2019 Oct; 143():80-90. PubMed ID: 31446044
[TBL] [Abstract][Full Text] [Related]
35. Skin Metabolism: Relevance of Skin Enzymes for Rational Drug Design.
Pyo SM; Maibach HI
Skin Pharmacol Physiol; 2019; 32(5):283-294. PubMed ID: 31357203
[TBL] [Abstract][Full Text] [Related]
36. Localized and targeted delivery of NSAIDs for treatment of inflammation: A review.
Haley RM; von Recum HA
Exp Biol Med (Maywood); 2019 Apr; 244(6):433-444. PubMed ID: 29996674
[TBL] [Abstract][Full Text] [Related]
37. Strategies for meloxicam delivery to and across the skin: a review.
Chen J; Gao Y
Drug Deliv; 2016 Oct; 23(8):3146-3156. PubMed ID: 26956920
[TBL] [Abstract][Full Text] [Related]
38. Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain--biopharmaceutic and pharmacokinetic challenges.
Srinivas NR
Eur J Drug Metab Pharmacokinet; 2009; 34(1):7-10. PubMed ID: 19462922
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
